The use of antihypertensive therapy in Spain (1986-1994)

American Journal of Hypertension

Volumn 13, Issue 6 II SUPPL., 2000, Pages 607-610

  Suliman Jabary, Najaty ^a   Mendiluce Herrero, Alicia ^a   Alvarez Gonzalez, Javier ^a  

^a HOSPITAL CLÍNICO UNIVERSITARIO DE VALLADOLID   (Spain)

Author keywords

Hypertension; Hypotensive drug consumption; Prescription pattern

Indexed keywords

ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; AMLODIPINE; ANTIHYPERTENSIVE AGENT; BENAZEPRIL; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM ANTAGONIST; CAPTOPRIL; CILAZAPRIL; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; ENALAPRIL; FOSINOPRIL; LISINOPRIL; NIFEDIPINE; PERINDOPRIL; QUINAPRIL; RAMIPRIL; VERAPAMIL;

ANTIHYPERTENSIVE THERAPY; ARTICLE; CONTROLLED STUDY; DRUG USE; HUMAN; HYPERTENSION; PRESCRIPTION; PRIORITY JOURNAL; SPAIN;

ADRENERGIC BETA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANTIHYPERTENSIVE AGENTS; CALCIUM CHANNEL BLOCKERS; DIURETICS; DRUG UTILIZATION; HUMANS; HYPERTENSION; PRESCRIPTIONS, DRUG; RETROSPECTIVE STUDIES; SPAIN;

EID: 0033928229     PISSN: 08957061     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0895-7061(99)00261-7     Document Type: Review

References (27)

1. Martín Arias L (eds.): Drug Consumption in Spain. Secretaria de Publicaciones Universidad, Valladolid, 1994.
2. Gross TP, Wise RP, Knapp DE: Antihypertensive drug use. Trends in the United States from 1973 to 1985. Hypertension 1989;13(5 suppl):I113-I118.
3. Rolland F, Lafont J, Montastruc JL, Montastruc P: Development of antihypertensive drug consumption in the Toulouse University Regional Hospital Centre from 1981 to 1989. Therapies 1991;46(I):45-48.
4. Siegel D, Lopez J: Trends in antihypertensive drug use in the United States: do the JNC V recommendations affect prescribing? Fifth Joint National Committee on the Detection, Evaluation, and Treatment of High Blood Pressure. JAMA 1997;278(21):1745-1748.
5. Hurley SF, Williams SL, McNeil JJ: Trends in prescribing of antihypertensive drugs in Australia, 1977-1987. Med J Aust 1990;5:152(5):259-260.
6. Coca A. Control of hypertension in Spain. Results of Controlpres 95 study. Hypertensión 1995;12:182-188.
7. The Joint National Committee On Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: The Sixth Report. Arch Intern Med 1997;157:2413-2446.
8. The Joint National Committee On Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The 1988 Report: A Co-operative study. Arch Intern Med 1988;148:1023-1038.
9. The Joint National Committee On Prevention, Detection, Evaluation, and Treatment of High Blood Pressure. The Fifth Report: A Co-operative study. Arch Intern Med 1993;153:154-183.
10. 1993 guidelines for the management of mild hypertension: memorandum from a WHO/ISH meeting. J Hypertens 1993;11:903-919.
11. MacMahon S, Peto R, Cutler J, Collins R, Sortie P, Neaton J, Abbot R, Godwin J, Dyer A, Stamler J: Blood pressure, stroke and coronary heart disease. Part I. Prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990;335:765-774.
12. Kawachi I, Malcolm LA, Purdie G: Variability in antihypertensive drug therapy in general practice: results from random national survey. NZ Med J 1989; 28: 102(870):307-309.
13. Wallenius S, Peura S, Klaukka T, Ennlund H: Who is using antihypertensive drugs? A prescription analysis from Finland. Scand J Prim Health Care 1996;14(1):54-61.
14. Psaty BM, Koepsell TD, Yanez ND, Smith NL, Manolio TA, Heckbert SR, Borhani JM, Gottdiener JS, Rutan GH, Siscovich DS, Furberg CD: Temporary patterns of antihypertensive medication use among adults, 1989 through 1992. JAMA 1995;273:1436-1438.
15. Soumaeri SB: Factors influencing prescribing. Aust J Hosp Pharm 1988;18(suppl):9-16.
16. Soumerai SB, McLaughlin TJ, Avorn J: Improving drug prescribing in primary care: a critical analysis of the experimental literature. Milbank Q 1989;67:268-317.
17. Wilkes MS, Doblin BH, Shapiro MF: Pharmaceutical advertisements in leading medical journals: experts assessments. Ann Intern Med 1992;116:912-919.
18. Bergamn U, Grimsson A, Wahba AHW, Westergilm B (eds.): Studies in Drug Utilisation. Methods and Applications. WHO Regional Office for Europe, Copenhagen, 1979.
19. Garcia Iñesta A: Drug consumption studies in Spain, an analysis of pharmacotherapeutical situation, in Institute Nacional de la Salud (eds): Estudios de utlización de medicamentos. Instituto Nacional de la Salud, Madrid, 1988, pp. 27-29.
20. Norwegian Medicinal Depot: The Drug Consumption in Norway 1981-1985. Norwegian Medicinal Depot, Oslo, 1986, p 91.
21. Lee PK, Li RK, Chan JR, Chan S, Lee SC, Tomlison B, Critchley JA: A prescription survey in a hospital hypertension outpatient clinic. Br J Clin Pharmacol 1997;44: 577-582.
22. Rotmensch HH, Mendelevitch L, Silverberg DS, Liron M: Prescribing pattern of antihypertensive drugs in the community. J Hum Hypertens 1996;(Suppl 3):S169-S172.
23. SHEP Co-operative Research Group: Prevention of stroke by antihypertensive drug treatment in older persons with isolated systolic hypertension: final results of the Systolic Hypertension in the Elderly Program (SHEP). JAMA 1991;265:3255-3264.
24. Dahlof B, Lindholm LH, Hansson L, Schersten B, Ekbom T, Wester PO: Morbidity and mortality in the Swedish Trial in Old Patients with hypertension (STOP-Hypertension). Lancet 1991;338:1281-1285.
25. Medical Research Council Working Party: Medical Research Council trial of treatment of hypertension in older adults: principal results. Br Med J 1992;304:405-412.
26. Grupos terapeúticos y principios activos de mayor consumo en el Sistema Nacional de Salud durante 1996. Información Terapéutica del Sistema Nacional de Salud. 1997;21:153-156.
27. 1995 Drug Topics Redbook. Medical Economics Publishing, Montvale, NJ, 1995.